Add BrightSurf on Google Email

UBC enzyme technology clears first human test toward universal donor organs for transplantation

Researchers at UBC have successfully transplanted an enzyme-converted kidney into a brain-dead recipient, showing promise for universal donor organs in transplantation. The breakthrough uses special enzymes to remove blood-type antigens, making it possible to use mismatched organs from deceased donors.

SourceUniversity of British Columbia·JournalNature Biomedical Engineering·TypeExperimental study·DateOct 3, 2025

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Researchers have engineered a monoclonal antibody that blocks allergic reactions against common pollen when applied inside the nose of mice, providing new hope for hay fever sufferers. The treatment, known as a 'molecular shield,' acts immediately and locally at the lining of the nose to prevent IgE antibodies from being activated.

SourceFrontiers·JournalFrontiers in Immunology·TypeExperimental study·DateJul 11, 2025
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New credit card-sized TB test could close the diagnostic gap in HIV hotspots

Researchers at Tulane University developed a handheld TB test inspired by the bombardier beetle's natural defense mechanism. The ASTRA device requires only a drop of blood and delivers same-day diagnoses without need for laboratory or trained staff, outperforming traditional tests in detection of TB with HIV co-infection.

SourceTulane University·JournalNature Biomedical Engineering·DateJun 27, 2025

Neoself-antigens induce autoimmunity in lupus

Researchers found that neoself-antigens, presented on MHC-II, induce an immune response and lead to autoimmunity in lupus patients. EBV reactivation increases the presentation of these antigens, triggering T cell activation and autoimmune disease development.

SourceImmunology Frontier Research Center (IFReC) - Osaka University·JournalCell·TypeExperimental study·DateSep 13, 2024

Key protein linked to immune disorders

Researchers found that STAP-1 plays a crucial role in activating T cells, which are white blood cells critical to defending against infections and maintaining overall health. The study suggests that STAP-1 may be involved in the development of immune disorders such as multiple sclerosis and asthma.

SourceHokkaido University·JournalThe Journal of Immunology·TypeExperimental study·DateMar 11, 2024
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Breakthrough T cell discovery has huge potential for engineering custom immune responses

Researchers at Institute for Systems Biology have made a breakthrough discovery about T cells, finding that the genetically encoded T-cell receptor sequence determines a T cell's function. This fundamental discovery has huge potential for developing custom immune responses to specific antigens.

SourceInstitute for Systems Biology·JournalCell Reports·TypeRandomized controlled/clinical trial·DateOct 25, 2023

The double face of RNase as a treatment for systemic autoimmune diseases

Researchers from Osaka University found that RNase treatments can either enhance or weaken immune activation in systemic autoimmune diseases. The study suggests that the composition of immune complexes plays a crucial role in determining the effectiveness of RNase treatment.

SourceOsaka University·JournalJCI Insight·TypeExperimental study·DateJul 18, 2023

Creating artificially engineered organs could become quicker and easier

Researchers have developed a new manufacturing pipeline to simplify and advance high-value manufacturing of tissue-compatible organs, reducing costs and increasing efficiency. This breakthrough aims to address the dire need for artificially engineered organs and tissue grafts, potentially saving thousands of lives in the UK.

SourceUniversity of Huddersfield·JournalAdvanced Healthcare Materials·TypeImaging analysis·DateJun 12, 2023

Immunotherapy reduces lung and liver fibrosis in mice

Researchers at the University of Zurich have developed a new immunotherapy strategy to eliminate fibroblasts in targeted manner, reducing lung and liver fibrosis in mice. The treatment triggers an immune response via cytotoxic T-cells, eliminating activated connective tissue cells while leaving resting cells undamaged.

SourceUniversity of Zurich·JournalCell Stem Cell·TypeExperimental study·DateSep 15, 2022
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.